Get the full picture
Sign in to uncover key details.
Aptevo Therapeutics
Business Services · Washington, United States · 11-50 Employees
View Company Info for Free
Overview
Headquarters
2401 4th Ave Ste 1050, Seattle, Washingt...Phone Number
(206) 838-0500Website
www.aptevotherapeutics.comRevenue
-Stock Symbol
APVOIndustry
About Aptevo Therapeutics
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company headquartered in Seattle, Washington, focused on developing bispecific and trispecific immunotherapies for cancer. Its pipeline is built on proprietary ADAPTIR and ADAPTIR-FLEX protein technology platforms designed to create multispecific antibody candidates that enhance immune responses against cancer cells. Its lead candidate, mipletamig, is being evaluated in a Phase 1b/2 trial for frontline acute myeloid leukemia in combination with venetoclax and azacitidine. Aptevo also develops additional candidates for solid tumors and blood cancers and trades on Nasdaq under the ticker APVO.Explore more
Aptevo Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Aptevo Therapeutics
Compare insights from companies similar to Aptevo Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
$132.7M
51-200
Public
$547.1M
1994
JB
Jennifer BuellPresident and CEO of MiNK Therapeutics, Chairman, Executive Council At Agenus
Aptevo Therapeutics Tech Stack
A closer look at the technologies used by Aptevo Therapeutics
See more technologies
Top Business Services Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Frequently Asked Questions Regarding Aptevo Therapeutics
Sign Up For FreeTo access detailed company insights
Aptevo Therapeutics Inc. is a clinical-stage biotechnology company headquartered in Seattle, Washington, focused on developing bispecific and trispecific immunotherapies for cancer. Its pipeline is built on proprietary ADAPTIR and ADAPTIR-FLEX protein technology platforms designed to create multispecific antibody candidates that enhance immune resp... Read More
